期刊文献+

腰-硬联合阻滞麻醉穿刺失败改用硬膜外腔阻滞麻醉辅助酒石酸布托啡诺对剖宫产新生儿的影响 被引量:3

腰-硬联合阻滞麻醉穿刺失败改用硬膜外腔阻滞麻醉辅助酒石酸布托啡诺对剖宫产新生儿的影响
下载PDF
导出
摘要 目的:探讨硬膜外腔阻滞麻醉辅助酒石酸布托啡诺对剖宫产新生儿的影响情况。方法:2005年2月~2011年12月收治ASAⅠ~Ⅱ级产妇腰-硬联合阻滞麻醉穿刺失败改用硬膜外腔阻滞麻醉的剖宫产患者127例,随机分成两组,A组为因硬膜外阻滞不全而辅用酒石酸布托啡诺的病例;B组硬膜外阻滞满意。结果:根据麻醉情况,A组53例,B组74例,两组新生儿Apgar评及术后情况:A组Apgar1分钟8.9±0.9分,Apgar5分钟9.9±0.5分,B组Apgar1分钟8.7±0.9分,Apgar5分钟9.8±0.6分,两组比较无显著性差异(P>0.05),A组53例产妇中有恶心、呕吐15例(28%),头晕3例(6%);B组74例产妇中有恶心、呕吐16例(22%)。A组不良反应略高于B组。结论:硬膜外腔阻滞麻醉辅助酒石酸布托啡诺对剖宫产新生儿无明显影响。 Objective:To investigate the joint block anesthesia assisted tartrate butorphanol cesarean section newborns. Methods:before February 2011 to December ASA I I1 level surgery 350 cases of fetal distress cesarean section were randomly divided into two groups, group A because of incomplete epidural block and auxiliary tartrate cloth care to brown the promise of the cases; Group B epidural anesthesia. Results: According to the anesthesia situation, A group of 110 cases, 240 cases of B, two groups of neonatal Apgar assessment and postoperative : A group Apgar 1 rain : 8.9 ± 0. 9, Apgar 5min 9. 9 ±0. 5 group B Apgarlmin and for :8.7±0. 9, Apgar 5rain 9. 8 ±0. 6 points, the two groups showed no significant differ-ence(P 〉 0. 05), A group of 110 cases of maternal nausea, vomiting, 10 cases (9. 1% ), dizziness, 7 cases, accounting for 4% ;Group B,240 cases of maternal nausea, vomiting 3 cases, accounting for 1.25%. Group A side effect of slightly higher than the B group. Conclusion:The joint block anesthesia assisted tartrate butorphanol had no significant effect of cesarean section newborns.
出处 《中国社区医师(医学专业)》 2012年第12期84-84,共1页
关键词 酒石酸布托啡诺 硬膜外腔阻滞麻醉 剖宫产 新生儿 影响 Tartrate butorphanol promise Joint block anesthesia Cesarean section Newborn Impact
  • 相关文献

参考文献2

  • 1乐杰;谢幸.妇产科[M]北京:人民卫生出版社,200827.
  • 2Danelli G,F anelli G,Berti M. Spinal ropivacaine or bupivacaine for cesarean delivery:a prospective,randomized,doubleblind comparison[J].Reg Anesth P ain Med,2004.221-226.

同被引文献37

  • 1沈国容,王东明,赵志斌,徐德明.布托啡诺与芬太尼应用于全麻诱导期间呼吸循环变化的临床对照研究[J].陕西医学杂志,2005,34(10):1241-1243. 被引量:18
  • 2Dunteman E. Karanikolas M. Fdos KS Transnasal butorphanol for the treatment of opioidmduced pruritus un- responsive to antihistamines [ J ]. Journal of pain and symptom management, 1996 , 12 ( 4 ) :255-260.
  • 3Halter JB, Pflug AE, Poae D. Mechanisms of plasma cate- cholamine increases during surgical stress in man [ J ]. J Clin Endocrinol Metab , 1997 ,45:936.
  • 4Chandni Sinha, Manpreet Kaur, Ajeet Kumar. Comparative evaluation of midazolam and butorphanol as oral premedication in pediatric patients [ J J. Anaesthesiol Clin Pharmacol. , 2012 ,28 ( 1 ) : 32-35.
  • 5Kain ZN, Mayes LC, Bell C, et al. Premeditation in the United States : A status report [ J ]. Anesth Analg, 1997 , 84 (4) :27-32.
  • 6Bhakta P, Ghosh BR, Roy M, et al. Evaluation of Intranasal midazolam for preanasthetic sedation in Paediatric patients [ J]. Indian J Anaesth ,2007 ,51 ( 11 ) : 1-6.
  • 7Lnnqvist PA, Habre W. Midazolam as premedication: Is the emperor naked or just half- dressed? [ J ]. Pediatr Anesth ,2005 ,15(26) :3-5.
  • 8Bergendahl H, Lonnqvist PA, Eksborg S. Clonidine in paediatric anaesthesia: A review of the literature and comparison with benzodiazepines for premedication [ J ]. Acta Anaesthesiol Scand,2006 ,50( 1 ) :35-43.
  • 9Schmidt AP, Valinetti EA, Banderira D, et al. Jr Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children [ J ]. Paediatr Anaesth, 2007 , 17 ( 6 ) : 67-74.
  • 10Wittles B, glisten B, Faure EA, et al. Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternaloutcomes [ J ]. Anesthanalg, 1993 ,77:925-932.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部